FR2474314B1 - - Google Patents

Info

Publication number
FR2474314B1
FR2474314B1 FR8027815A FR8027815A FR2474314B1 FR 2474314 B1 FR2474314 B1 FR 2474314B1 FR 8027815 A FR8027815 A FR 8027815A FR 8027815 A FR8027815 A FR 8027815A FR 2474314 B1 FR2474314 B1 FR 2474314B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8027815A
Other languages
French (fr)
Other versions
FR2474314A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Byk Mallinckrodt CIL BV
Original Assignee
Byk Mallinckrodt CIL BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Mallinckrodt CIL BV filed Critical Byk Mallinckrodt CIL BV
Publication of FR2474314A1 publication Critical patent/FR2474314A1/fr
Application granted granted Critical
Publication of FR2474314B1 publication Critical patent/FR2474314B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nuclear Medicine (AREA)
FR8027815A 1979-12-31 1980-12-30 Solution aqueuse de dosage radiologique pour animaux a sang chaud Granted FR2474314A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/108,575 US4348375A (en) 1979-12-31 1979-12-31 Radioassay process and compositions useful therein

Publications (2)

Publication Number Publication Date
FR2474314A1 FR2474314A1 (fr) 1981-07-31
FR2474314B1 true FR2474314B1 (2) 1984-10-05

Family

ID=22322962

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8027815A Granted FR2474314A1 (fr) 1979-12-31 1980-12-30 Solution aqueuse de dosage radiologique pour animaux a sang chaud

Country Status (14)

Country Link
US (1) US4348375A (2)
JP (2) JPS56103118A (2)
AT (1) AT368889B (2)
BE (1) BE886930A (2)
CA (1) CA1155372A (2)
CH (1) CH652308A5 (2)
DE (1) DE3049533A1 (2)
DK (1) DK556880A (2)
ES (1) ES8202154A1 (2)
FR (1) FR2474314A1 (2)
GB (1) GB2066664B (2)
IT (1) IT1193721B (2)
NL (1) NL8007094A (2)
SE (1) SE451798B (2)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443426A (en) * 1982-06-14 1984-04-17 Yale University Blood agent
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US5376356A (en) * 1989-03-14 1994-12-27 Neorx Corporation Imaging tissue sites of inflammation
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
US5524622A (en) * 1994-09-20 1996-06-11 Oregon Health Sciences University Non-invasive method of determining inflammation of the gastrointestinal tract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017596A (en) * 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
CA1070695A (en) * 1975-09-02 1980-01-29 Michael D. Loberg Iminodiacetic acid pharmaceutical
FR2390408A1 (fr) * 1977-05-11 1978-12-08 Philips France Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition

Also Published As

Publication number Publication date
ES498236A0 (es) 1982-01-01
CH652308A5 (de) 1985-11-15
GB2066664B (en) 1984-06-20
FR2474314A1 (fr) 1981-07-31
JPS56103118A (en) 1981-08-18
DK556880A (da) 1981-07-01
SE451798B (sv) 1987-11-02
AT368889B (de) 1982-11-25
ES8202154A1 (es) 1982-01-01
IT8069013A0 (it) 1980-12-30
DE3049533A1 (de) 1981-09-17
NL8007094A (nl) 1981-08-03
ATA635880A (de) 1982-04-15
CA1155372A (en) 1983-10-18
BE886930A (fr) 1981-04-16
US4348375A (en) 1982-09-07
IT1193721B (it) 1988-08-24
SE8009185L (sv) 1981-07-01
GB2066664A (en) 1981-07-15
JPH02117623A (ja) 1990-05-02

Similar Documents

Publication Publication Date Title
FR2448824B1 (2)
FR2446186B1 (2)
FR2471474B1 (2)
GR68460B (2)
FR2449411B1 (2)
DE3050570A1 (2)
FR2449173B3 (2)
GR68428B (2)
CH660830GA3 (2)
FR2448492B1 (2)
FR2501780B3 (2)
FR2474314B1 (2)
FR2447624B3 (2)
FR2448344B1 (2)
FR2447925B1 (2)
JPS55115613U (2)
JPS55108445U (2)
FR2446738B1 (2)
FR2447317B2 (2)
GR74001B (2)
JPS55116345U (2)
FR2445993B1 (2)
FR2446789B1 (2)
FR2446037B3 (2)
FR2449134B1 (2)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse